We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Fovea Pharmaceuticals SA (Fovea), a biopharmaceutical company created in May 2005 by a team of experienced scientists and managers, announced today the closing of a EUR20.5 million ($25 million) equity financing round.
The OTC drug market in Israel is worth US$130mn per year and grew at an annual rate of 5% between 2000 and 2004, according to a recent study by Derby University's Israel branch.
The consumer price of pharmaceuticals in Peru, rose just 0.1% in October, significantly below inflation, due to strong competition among pharmaceutical chains and the government's continuing support of generic provision.
The growing use of orphan drugs -- medications used to treat rare diseases and conditions -- by UK healthcare provider the National Health Service (NHS) is straining budgets, according to two new articles published in the British Medical Journal.
The Philippine government is introducing new measures aimed at expanding the country's drug distribution network and increasing both the access and affordability of high-standard medicines.
Javelin Pharmaceuticals, Inc. (OTC BB: JVPH) announced today that it has entered into definitive purchase agreements in a private placement of its common stock and warrants totaling approximately $32 million.
rk Therapeutics Group PLC said it has received a 2.19 mln eur grant from the Employment and Economic Development Centre of Finland for its new GMP manufacturing facility.
Australian drug development company Alchemia Limited (ASX: ACL) today announced it had raised $14.6 million through an institutional and sophisticated investor share placement and would commence a share purchase plan (SPP) to offer an additional $5 million to existing shareholders to fund the progression of its promising drug discovery programs.